from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv3466/-

LFCtreatmentdescriptionclass of inhibitor

-0.591

Amikacinug/mL Amikacintranslation

-0.520

Cap5-10ug/mL Capreomycintranslation

-0.973

Rox10-50 ug/mL Roxithromycintranslation

-0.836

SM2-5 ug/mL Streptomycintranslation

-0.362

Tet5-10 ug/mL Tetracyclinetranslation

-0.007

Rif0.2-5ug/mL Rifampicintranscription

-0.630

Rifp0.1-0.5ug/mL Rifapentinetranscription

-1.089

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

1.161

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

-0.250

CPZ10-50 ug/mL Chlorpromazinerespiration

0.814

Clofazimine10-13 ug/mL Clofaziminerespiration

-0.110

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

1.086

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

2.977

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

-0.083

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

-0.023

Econazole10-24 ug/mL Econazole (azole drug)respiration

-0.449

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

-0.264

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

1.533

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

0.167

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

2.627

KCN5-20 ug/mL Potassium cyaniderespiration

0.118

NaN30.2-2 mM Sodium aziderespiration

0.913

Nigericin50 uM Nigericinrespiration

0.799

TRC10-150 ug/mL Triclosanrespiration

1.497

TRZ10-25 ug/mL Thioridazinerespiration

0.329

Valinomycin0.5-10 uM Valinomycinrespiration

-0.823

ZnSO42 mM ZnSO4respiration

0.357

menadione6-10 ug/mL Menadionerespiration

-0.204

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

-0.715

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

-0.479

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

-0.625

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

-0.728

NRP_1Non-replicating persistence stage 1dosRassociated

-0.606

Amp0.2mg/mL AmpicillincellWall

-0.539

Cephalexin20-100 ug/mL CephalexincellWall

-0.258

Cerulenin0.32-5 ug/mL CerulenincellWall

-0.423

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

-0.428

EMB10-20 ug/mL EthambutolcellWall

-0.886

Eta12-40 ug/mL EthionamidecellWall

-1.009

INH0.2-0.4 ug/mL IsoniazidcellWall

-0.482

TLM0.1-0.2 mg/mL ThiolactomycincellWall

-0.540

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.405

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.290

BZA0.12 mg/mL BenzamidearomaticAmides

0.157

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

0.006

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

0.500

H2O24 mM hydrogen peroxideDNAdamaging

3.826

Levo10 ug/mL LevofloxacinDNAdamaging

-0.191

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

3.063

Novobiocin10 ug/mL NovobiocinDNAdamaging

1.911

Oflox5-10 ug/mL OfloxacinDNAdamaging

0.313

UVUV-irradiationDNAdamaging

0.271

ARP41-4 ug/mL Antitubercular compound ARP4?

-0.443

Antimycin12.5-50 ug/mL Antimycin A?

-0.517

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

-0.328

PA_110-50 ug/mL Antitubercular compound PA-1?

-0.276

PA_2110-50 ug/mL Antitubercular compound PA-21?

1.775

PA8240.2-2 ug/mL PA-824?

0.036

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

-0.238

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

-0.640

Verapamil50 uM Verapamil?

-0.360

mercaptoethanol2 mM 2-Mercaptoethanol?

0.048

methoxatin10-20 ug/mL Methoxatin?